Pathogen Evasion of Chemokine Response Through Suppression of CXCL10.
Journal: 2019/August - Frontiers in Cellular and Infection Microbiology
ISSN: 2235-2988
Abstract:
Clearance of intracellular pathogens, such as Leishmania (L.) major, depends on an immune response with well-regulated cytokine signaling. Here we describe a pathogen-mediated mechanism of evading CXCL10, a chemokine with diverse antimicrobial functions, including T cell recruitment. Infection with L. major in a human monocyte cell line induced robust CXCL10 transcription without increasing extracellular CXCL10 protein concentrations. We found that this transcriptionally independent suppression of CXCL10 is mediated by the virulence factor and protease, glycoprotein-63 (gp63). Specifically, GP63 cleaves CXCL10 after amino acid A81 at the base of a C-terminal alpha-helix. Cytokine cleavage by GP63 demonstrated specificity, as GP63 cleaved CXCL10 and its homologs, which all bind the CXCR3 receptor, but not distantly related chemokines, such as CXCL8 and CCL22. Further characterization demonstrated that CXCL10 cleavage activity by GP63 was produced by both extracellular promastigotes and intracellular amastigotes. Crucially, CXCL10 cleavage impaired T cell chemotaxis in vitro, indicating that cleaved CXCL10 cannot signal through CXCR3. Ultimately, we propose CXCL10 suppression is a convergent mechanism of immune evasion, as Salmonella enterica and Chlamydia trachomatis also suppress CXCL10. This commonality suggests that counteracting CXCL10 suppression may provide a generalizable therapeutic strategy against intracellular pathogens.

Importance
Leishmaniasis, an infectious disease that annually affects over one million people, is caused by intracellular parasites that have evolved to evade the host's attempts to eliminate the parasite. Cutaneous leishmaniasis results in disfiguring skin lesions if the host immune system does not appropriately respond to infection. A family of molecules called chemokines coordinate recruitment of the immune cells required to eliminate infection. Here, we demonstrate a novel mechanism that Leishmania (L.) spp. employ to suppress host chemokines: a Leishmania-encoded protease cleaves chemokines known to recruit T cells that fight off infection. We observe that other common human intracellular pathogens, including Chlamydia trachomatis and Salmonella enterica, reduce levels of the same chemokines, suggesting a strong selective pressure to avoid this component of the immune response. Our study provides new insights into how intracellular pathogens interact with the host immune response to enhance pathogen survival.

Relations:
Content
Citations
(3)
Diseases
(1)
Conditions
(1)
Chemicals
(1)
Genes
(8)
Organisms
(5)
Processes
(3)
Anatomy
(4)
Affiliates
(1)
Similar articles
Articles by the same authors
Discussion board
Front Cell Infect Microbiol 9: 280

Pathogen Evasion of Chemokine Response Through Suppression of CXCL10

+2 authors
Click here for additional data file.(18M, docx)
Department of Molecular Genetics and Microbiology, School of Medicine, Duke University, Durham, NC, United States
Department of Biochemistry, School of Medicine, Duke University, Durham, NC, United States
Division of Cardiology, Department of Medicine, School of Medicine, Duke University, Durham, NC, United States
Proteomics and Metabolomics Shared Resource, Center for Genomics and Computational Biology, School of Medicine, Duke University, Durham, NC, United States
Department of Biomedical Research, National Jewish Health, Denver, CO, United States
Department of Immunology and Microbiology, University of Colorado Anschutz Medical Campus, Aurora, CO, United States
Division of Infectious Diseases, Department of Medicine, School of Medicine, Duke University, Durham, NC, United States
Edited by: Claudia Ida Brodskyn, Gonçalo Moniz Institute (IGM), Brazil
Reviewed by: Albert Descoteaux, Institut National de la Recherche Scientifique (INRS), Canada; Nicolaus Albert Borges Schriefer, Federal University of Bahia, Brazil
*Correspondence: Dennis C. Ko ude.ekud@ok.sinned; @denniskoHiHOST
This article was submitted to Parasite and Host, a section of the journal Frontiers in Cellular and Infection Microbiology
Edited by: Claudia Ida Brodskyn, Gonçalo Moniz Institute (IGM), Brazil
Reviewed by: Albert Descoteaux, Institut National de la Recherche Scientifique (INRS), Canada; Nicolaus Albert Borges Schriefer, Federal University of Bahia, Brazil
Received 2019 May 10; Accepted 2019 Jul 23.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

Abstract

Clearance of intracellular pathogens, such as Leishmania (L.) major, depends on an immune response with well-regulated cytokine signaling. Here we describe a pathogen-mediated mechanism of evading CXCL10, a chemokine with diverse antimicrobial functions, including T cell recruitment. Infection with L. major in a human monocyte cell line induced robust CXCL10 transcription without increasing extracellular CXCL10 protein concentrations. We found that this transcriptionally independent suppression of CXCL10 is mediated by the virulence factor and protease, glycoprotein-63 (gp63). Specifically, GP63 cleaves CXCL10 after amino acid A81 at the base of a C-terminal alpha-helix. Cytokine cleavage by GP63 demonstrated specificity, as GP63 cleaved CXCL10 and its homologs, which all bind the CXCR3 receptor, but not distantly related chemokines, such as CXCL8 and CCL22. Further characterization demonstrated that CXCL10 cleavage activity by GP63 was produced by both extracellular promastigotes and intracellular amastigotes. Crucially, CXCL10 cleavage impaired T cell chemotaxis in vitro, indicating that cleaved CXCL10 cannot signal through CXCR3. Ultimately, we propose CXCL10 suppression is a convergent mechanism of immune evasion, as Salmonella enterica and Chlamydia trachomatis also suppress CXCL10. This commonality suggests that counteracting CXCL10 suppression may provide a generalizable therapeutic strategy against intracellular pathogens.

Importance

Leishmaniasis, an infectious disease that annually affects over one million people, is caused by intracellular parasites that have evolved to evade the host's attempts to eliminate the parasite. Cutaneous leishmaniasis results in disfiguring skin lesions if the host immune system does not appropriately respond to infection. A family of molecules called chemokines coordinate recruitment of the immune cells required to eliminate infection. Here, we demonstrate a novel mechanism that Leishmania (L.) spp. employ to suppress host chemokines: a Leishmania-encoded protease cleaves chemokines known to recruit T cells that fight off infection. We observe that other common human intracellular pathogens, including Chlamydia trachomatis and Salmonella enterica, reduce levels of the same chemokines, suggesting a strong selective pressure to avoid this component of the immune response. Our study provides new insights into how intracellular pathogens interact with the host immune response to enhance pathogen survival.

Keywords: CXCL10, CXCR3, Leishmania, gp63, leishmanolysin, Chlamydia, Salmonella, convergent evolution
Abstract

Acknowledgments

We thank Robyn Guo for assistance with immunoblotting, Sarah Rains for assistance with sample prep for CXCL10 cleavage site identification, and Jeffrey S. Bourgeois for thoughtful discussion about experimental design and analysis. For assistance with screening additional pathogens for CXCL10 cleavage we thank Emily Derbyshire, Maria Toro-Moreno, David Tobin, Ana-María Xet-Mull, Raphael Valdivia, Qin Yan, Vance Fowler, Jennifer Tenor, and John Perfect. We thank the Duke University School of Medicine for the use of the Proteomics and Metabolomics Shared Resource.

Acknowledgments

Footnotes

Funding. AA, KG, ET, KP, BS, and DK were supported by Duke Molecular Genetics and Microbiology startup funds, Duke University Whitehead Scholarship, Butler Pioneer Award, and NIH U19AI084044. ET was supported by the Duke Summer Research Opportunity Program (SROP). AM was supported by the Duke Department of Molecular Genetics and Microbiology Summer Undergraduate Research Experience (MGM SURE). JS and SR were supported by NIH {"type":"entrez-nucleotide","attrs":{"text":"GM122798","term_id":"221993598","term_text":"GM122798"}}GM122798 and the Burroughs Wellcome Fund Career Award for Medical Scientists. RR was supported by NIH {"type":"entrez-nucleotide","attrs":{"text":"AI119004","term_id":"3519328","term_text":"AI119004"}}AI119004.

Footnotes
Click here for additional data file.(18M, docx)
Collaboration tool especially designed for Life Science professionals.Drag-and-drop any entity to your messages.